Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 study evaluating Tapinarof Cream 1% versus VTAMA for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of subcutaneous JS005 in adults with moderate to severe chronic plaque psoriasis has comple…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 study evaluating the efficacy and safety of D-2570 in adults with moderate-to-severe plaque psoriasis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period [Phase 3]
A Phase 3 study evaluates the efficacy and safety of TAK-279 for moderate-to-severe plaque psoriasis over 60 weeks, including withdrawal and…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis [NA]
An ongoing trial to evaluate the effectiveness and safety of a TYK2 inhibitor in adults with moderate to severe plaque psoriasis is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 multiple-dose escalation study of ASKP1240 in adults with moderate-to-severe plaque psoriasis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
This update reports the completion of an observational study of patients with moderate to severe chronic plaque psoriasis, sponsored by AbbV…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of TAK-279 in adults with moderate-to-severe plaque psoriasis over 52 weeks.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
A Phase 2 study evaluating LY3972406 in adults with moderate-to-severe plaque psoriasis has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults
A completed study evaluated treatment satisfaction, patient-reported outcomes, effectiveness, and safety of Calcipotriene/Betamethone Diprop…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
A Phase 3 trial comparing the efficacy and safety of Bmab 1200 versus Stelara (ustekinumab) in adults with moderate-to-severe chronic plaque…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis [Phase 3]
Phase 3 study of guselkumab in skin of color participants with moderate-to-severe plaque psoriasis and/or scalp psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
The document reports the completion of a long-term extension Phase 2 trial evaluating Janssen's investigational therapy JNJ-77242113 in adul…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
The document provides an update that a Phase 2 study of LY4100511 (DC-853) in adults with moderate-to-severe plaque psoriasis has been compl…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
A completed clinical trial evaluating whether PASI scoring for plaque psoriasis can be reliably performed using digital-based images. The st…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting [Phase 4]
A Phase 4 trial evaluated the effect of Deucravacitinib on quality of life in participants with plaque psoriasis in a community setting; res…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India [Phase 4]
A Phase 4 study evaluating ixekizumab for adults with plaque psoriasis or psoriatic arthritis in India has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment [Phase 3]
Phase 3 trial update for IBI112 in moderate-to-severe plaque psoriasis, involving randomized withdrawal and re-treatment; the study status i…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
This report covers the completion of a Phase 3 study evaluating the efficacy and safety of HLX03 in adults with moderate-to-severe plaque ps…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 [Phase 3]
This update reports on adverse events and changes in disease activity in pediatric participants aged 6 to 17 with moderate-to-severe plaque …
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating GNR-068, a ustekinumab biosimilar, versus Stelara for moderate-to-severe plaque psoriasis; study is active but not …
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis [Phase 3]
Phase 3 study comparing guselkumab versus placebo in patients with low body surface area moderate plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis [Phase 2]
Phase II study evaluating the clinical efficacy and safety of GN-037 in plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Ayurvedic Treatment Package in Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating an Ayurvedic treatment package for plaque psoriasis has completed. The excerpt does not provide trial re…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis [Phase 3]
Phase 3 trial evaluating tildrakizumab for nail psoriasis in chronic plaque psoriasis; results have been posted.